Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment with a novel peptide, SR-0379, for the Werner syndrome patients with limb ulcers

Trial Profile

Treatment with a novel peptide, SR-0379, for the Werner syndrome patients with limb ulcers

Completed
Phase of Trial: Phase II

Latest Information Update: 28 May 2018

At a glance

  • Drugs SR 0379 (Primary)
  • Indications Leg ulcer; Skin ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2018 Status changed from recruiting to completed.
    • 06 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top